 SAN DIEGO, Feb. 4, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced its financial results for the fourth quarter and full-year ended December 31, 2020 and provided full-year 2021 financial expense guidance. In 2020, we served more patients with tardive... 